Article

Overcoming Variants Resistance in Monoclonal Antibody for Antiviral Therapy

2023-11-06

Abstract excerpt

Monoclonal antibody (mAb) therapy has revolutionized the treatment of various diseases, including cancer and autoimmune disorders. However, the emergence of SARS-CoV-2 variants, as well as other pathogenic variants, poses challenges in maintaining the therapeutic efficacy of mAbs. In this mini review article, we aim to explore the strategies to overcome variants resistance in mAb therapy against viral infections....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1003377e-ce6c-5c8b-9153-4880fe407061
DOI: 10.20944/preprints202311.0307.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Overcoming Variants Resistance in Monoclonal Antibody for Antiviral TherapyDOI 10.20944/preprints202311.0307.v1Read

Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance.Semantic proximity Read

Monoclonal antibodies: From magic bullet to precision weaponSemantic proximity Read

Impact of BA.1, BA.2, and BA.4/BA.5 Omicron mutations on therapeutic monoclonal antibodies.Semantic proximity Read

Bebtelovimab-bound SARS-CoV-2 RBD mutants: resistance profiling and validation with escape mutations, clinical results, and viral genome sequences.Semantic proximity Read

Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants.Semantic proximity Read

A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversificationSemantic proximity Read

Dissecting the impact of somatic hypermutation on SARS-CoV-2 neutralization and viral escapeSemantic proximity Read

Broad Neutralizing Antibodies Against SARS-CoV-2: Current Progress and Engineering Strategies.Semantic proximity Read

Optimizing the breadth of SARS-CoV-2-neutralizing antibodies in vivo and in silicoSemantic proximity Read

In silico evaluation of ten monoclonal antibodies neutralization power of SARS-CoV-2 variants EG.5, BA.2.86 and JN.1Semantic proximity Read

Atlas of Currently-Available Human MAbs and Escape to Newly-Emerging Omicron BA.1/BA.1.1/BA.2/BA.3Semantic proximity Read

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19Semantic proximity Read